Senior insider sale
Chief Development Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$24.3K
2.97K shares
What this filing means
KAISER PETER plans to sell 2.97K shares of OCULAR THERAPEUTIX, INC valued at approximately $24.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/26/2026ACC: 0001950047-26-005067
Officer· Chief Development Officer
Since Feb 2026
2.97K
Shares to sell
$24.3K
Approx. market value
2.97K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
5/22/2026
2.97KTotal acquired2.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/22/2026 | Restricted stock vesting under a registered plan Not Applicable | 2.97K | — |
| Total | 2.97K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.97K
Market value
$24.3K
5/26/2026
Total
Units
2.97K
Value
$24.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/26/2026 | 2.97K | $24.3K | NASDAQ | Planned |
| Total | 2.97K | $24.3K | ||